Sander Robins, M.D.
Laboratory Director, Framingham Heart Study
Professor of Medicine, Boston University School of Medicine
73 Mt. Wayte Avenue
Framingham, MA 01702
Sander J. Robins, MD, is a Professor of Medicine at Boston University School of Medicine and is the Laboratory Director, Framingham Heart Study. Dr. Robins is a graduate of Dartmouth College and Jefferson Medical College. He completed residencies in medicine at New England Medical Center and Beth Israel Hospitals in Boston and a fellowship in gastroenterology at Boston University Medical Center. He is certified by the American Boards of Internal Medicine and Gastroenterology.
Dr. Robins has had a long-standing interest in hepatobiliary cholesterol metabolism and been funded by the NIH and the Department of Veterans Affairs for many years to determine the mechanism by which cholesterol is transported through the liver into bile and, particularly, how cholesterol from HDL is delivered to the liver to be preferentially secreted in bile. He was also Co-Principal Investigator of the Veterans Affairs HDL Cholesterol Intervention Trial (VA-HIT). This 7-year trial which was concluded in 1998, demonstrated for the first time that lipid therapy with a fibrate will significantly reduce the incidence of new coronary events and stroke in patients who have a low HDL-cholesterol but not a high-risk LDL-cholesterol.
Dr. Robins has presented his research at a number of national and international meetings and published research in a number of prestigious journals. He has served as an Associate Editor of the Journal of Lipid Research and is a member of the American Federation for Clinical Research, the American Gastroenterological Association, the American Association for the Study of Liver Diseases, and the American Heart Association.